Skip to main content

Biosynthesis and assembly of the factor VIII-von Willebrand factor complex

  • Conference paper
New Trends in Haemostasis

Abstract

Both factor VIII and the von Willebrand factor (vWF) serve an essential role in the hemostatic proces; factor VIII functions as a cofactor in the intrinsic coagulation pathway (van Dieijen et al. 1981; Mertens et al. 1985) whereas vWF is hemostatically important in the mediation of platelet-vessel wall interactions at sites of vascular injury (Tschopp et al. 1974; Sakariassen et al. 1979). In blood factor VIII and vWF are not present as distinct proteins but rather circulate as non-covalently linked complexes. Several lines of evidence indicate that this phenomenon is of physiological significance. For instance, it now seems clear that vWF functions as a carrier protein and as such has a stabilizing effect on factor VIII. This view stems from the observation that reduced or absent synthesis of vWF (as seen in von Willebrand’s disease) is accompanied with markedly reduced concentrations of plasma factor VIII (Ruggeri and Zimmerman 1987). Similarly, a rise in vWF concentration, as observed in disorders associated with acute-phase reactions, is accompanied with concommitant rises in plasma factor VIII concentrations (Bloom 1979). Taken into account that the half life of factor VIII infused in animals is determined by the presence of endogenous vWF (Brinkhous et al. 1985), these observations clearly illustrate that vWF not only binds to factor VIII but also confers stability to factor VIII in vivo.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bahou W F, Ginsburg D, Sikkink R, Litwiller R, Fass D N (1989) A monoclonal antibody to von Willebrand factor (vWF) inhibits factor VIII binding. J Clin Invest 84: 56

    Article  PubMed  CAS  Google Scholar 

  • Bloom A L, Giddings J C, Wilks C J (1973) Factor VIII on the vascular intima: possible importance in haemostsis and thrombosis. Nature New Biol 241: 217

    Article  PubMed  CAS  Google Scholar 

  • Bloom A L (1979) The biosynthesis of factor VIII. Clin Haemat 8: 53

    PubMed  CAS  Google Scholar 

  • Brinkhous K M, Sanberg H, Garvis J B, Mattsson C, Palm M, Griggs T, Read M S (1985) Purified human factor VIII procoagulant protein: comparative hemostatic response after infusion into hemophilic and von Willebrand disease dogs. Proc Natl Acad Sci USA 82: 8752

    Article  PubMed  CAS  Google Scholar 

  • Counts R B, Paskell S L, Elgee S K (1978) Disulfide bonds and the quarternary structure of factor VIII/von Willebrand factor. J Clin Invest 62: 792

    Article  Google Scholar 

  • Ewenstein N M, Warhol M J, Handin R I, Pober J S (1987) Composition of the von Willebrand factor storage organelle ( Weibel-Palade body) isolated from cultured human umbilical vein endothelial cells. J Cell Biol 104: 1423

    Google Scholar 

  • Fay P J, Kawai Y, Wagner D D, Ginsburg D, Bonthron D, OhlssonWilhelm B M, Chavin S I, Abraham G N, Handin R I, Orkin S H, Montgomery RR, Marder V (1986) Pro-polypeptide of von Willerband factor circulates in blood and is identical to von Willebrand antigen II. Science 232: 995

    Article  PubMed  CAS  Google Scholar 

  • Folkman J, Haudenschild C C, Zetter B R (1979) Long-term culture of cappillary endothelial cells. Proc Natl Acad Sci USA 76: 5217

    Article  PubMed  CAS  Google Scholar 

  • Foster P A, Fulcher C A, Marti T, Titani K, Zimmerman T S (1987) A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand afctor. J Biol Chem 262: 8443

    PubMed  CAS  Google Scholar 

  • Foster P A, Fulcher C A, Houghton R.A., Zimmerman T S (1988) An immunogenic region within amino acid residues Va11670-G1u1684 of the factor VIII light chain induces antibodies which inhibit binding of factor VIII to von Willebrand factor. J Biol Chem 263: 5230

    PubMed  CAS  Google Scholar 

  • Friederich E, Fritz H-J, Huttner W B (1988) Inhibition of Tyrosine sulfation in the trans-Golgi retards the transport of a constitutively secreted protein to the cell surface. J Cell Biol 107: 1655

    Article  PubMed  CAS  Google Scholar 

  • Hellman L, Smedsröd B, Sandberg H, Petterson U (1989) Secretion of coagulant factor VIII activity and antigen by in vitro cultivated rat liver sinusoidal endothelial cells. Brit J Haematol 73: 348

    Article  CAS  Google Scholar 

  • Higuchi M, Traystman M, Wong C, Olek K, Kazazian H H, Antonarakis S E (1989) Detection of point mutations in hemophilia A using PCR amplification of selected regions of the factor VIII gene. Thromb Haemostas 62: 201 (Abstract)

    Google Scholar 

  • Hortin G L, Farrier T C, Graham J P, Atkinson J P (1989) Sulfation of tyrosine residues increases activity of the fourth component of complement. Proc Natl Acad Sci USA 86: 1338

    Article  PubMed  CAS  Google Scholar 

  • Hoyer L W, de los Santos R P, Hoyer J R (1973) Antihemophilic factor antigen. Localization in endothelial cells by immunofluorescence microscopy. J Clin Invest 52: 2737

    Article  PubMed  CAS  Google Scholar 

  • Huttner W B, Baeuerle P A (1988) Protein sulfation on tyrosine. Modern cell Biology 6: 97

    CAS  Google Scholar 

  • Jaffe E A, Hoyer, L W, Nachman R L (1974) Synthesis of von Willebrand factor by cultured human endothelial cells. Proc Natl Acad Sci USA 71: 1906

    Article  PubMed  CAS  Google Scholar 

  • Levine J D, Harlan J M, Harker L A (1982) Thrombin-mediated release of factor VIII antigen from umbilical vein endothelial cells in culture. Blood 60: 531

    PubMed  CAS  Google Scholar 

  • Lewis J H, Bontempo F A, Spero J A, Ragni M V, Starzl T E (1985) Liver transplantation in a hemophiliac. N Engl J Med 312: 1189

    PubMed  CAS  Google Scholar 

  • Leyte A, Verbeet M Ph, Brodniewicz-Proba T, van Mourik J A, Mertens K, (1989) The interaction between human blood-coagulation factor VIII and von Willebrand factor. Biochem J 257: 697

    Google Scholar 

  • Leyte A, van Schijndel H B, Verbeet M Ph, Mertens K, van Mourik J A. The tyrosine sulfation site Tyr 1680 of human blood coagulation factor VIII is essential for the interaction of factor VIII with von Willebrand factor. Submitted for publication

    Google Scholar 

  • Loesberg C, Gonsalves M D, Zandbergen J, Willems Ch, van Aken W G, de Groot Ph G (1983) The effect of calcium on the secretion of factor VIII-related antigen by cultured human endothelial cells. Biochim Biophys Acta 763: 160

    CAS  Google Scholar 

  • Marti T, Rösselet S J, Titani K, Walsh K A (1987) Identification of disulfide-bridged substructures within human von Willebrand factor. Biochemistry 26: 8099

    Article  PubMed  CAS  Google Scholar 

  • Mazurier C, Dieval J, Jorieux S, Delobel J, Goudemand M (1990) A new von Willebrand factor (vWF) defect in a patient with factor VIII (FVIII) deficiency but with normal levels and multimeric patterns of both plasma and platelet vWF. Characterization of abnormal vWF/FVIII interaction. Blood 75: 20

    Google Scholar 

  • Mertens K, van Wijngaarden A, Bertina R M (1985) The role of factor VIII in the activation of human blood coagulation factor X by activated factor IX. Thromb Haemostas 54: 654

    CAS  Google Scholar 

  • Nachman R L, Levine R, Jaffe E A (1977) Synthesis of factor VIII antigen by cultured guinea pig megakaryocytes. J Clin Invest 60: 914

    Article  PubMed  CAS  Google Scholar 

  • Nishino M, Girma J P, Trothschild C, Fressinaud E, Meyer D (1989) New variant of von Willebrand disease with defective binding to factor VIII. Blood 74: 1591

    PubMed  CAS  Google Scholar 

  • Owen Ch A, Bowie E J W, Fass D N (1979) Generation of factor VIII coagulant activity by isolated, perfused neonatal perfused pig livers and adult rat livers. Brit J Haematol 43: 307

    Article  CAS  Google Scholar 

  • Owen W G, Wagner R H (1972) Antihemophilic factor: Separation of an active fragment following dissociation by salts or detergents. Thromb Diath Haemorrh 27: 502

    Google Scholar 

  • Pietu G, Ribba A S, Meulie P, Meyer D (1989) Localization within the 106 N-terminal amino acids of von Willerband factor (vWF) of the epitope corresponding to a monoclonal antibody which inhibits vWF binding to factor VIII. Biochem Biophys Res Comm 613: 618

    Article  Google Scholar 

  • Reinders J H, de Groot Ph G, Dawes J, Hunter N R, van Heugten H A A, Zandbergen J, Gonsalves M D, van Mourik J A (1985) Comparison of secretion and subcellular localization of von Willebrand protein with that of thrombospondin and fibronectin in cultured human vascular endothelial cells. Biochim Biophys Acta 844: 306

    CAS  Google Scholar 

  • Reinders J H, de Groot Ph G, Sixma J J, van Mourik J A (1988) Storage and secretion of von Willebrand factor by endothelial cells (1988) Haemostasis 18: 246

    PubMed  CAS  Google Scholar 

  • Ruggeri Z M, Zimmerman T S (1987) Von Willebrand factor and von Willebrand disease. Blood 70; 895

    PubMed  CAS  Google Scholar 

  • Sakariassen K S, Bolhuis P A, Sixma J J (1979) Human platelet adherence to artery subendothelium is mediated by factor VIII-von Willebrand factor bound to the subendothelium. Nature 279: 636

    Article  PubMed  CAS  Google Scholar 

  • Shaw E, Giddings J C, Peake I R, Bloom A L (1979) Synthesis of procoagulant factor VIII, factor VIII releated antigen and other coagulation factors by the isolated perfused rat liver. Brit J Haematol 41: 585

    Article  CAS  Google Scholar 

  • Sporn L A, Chavin S I, Marder V J (1985) Biosynthesis of von Willebrand protein by human megakaryocytes. J Clin Invest 76: 1102

    Article  PubMed  CAS  Google Scholar 

  • Sporn L A, Marder V J, Wagner D D (1986) Inducible secretion of large biologically potent von Willebrand factor multimers. Cell 46: 185

    Article  PubMed  CAS  Google Scholar 

  • Stel H V, van der Kwast Th H, Veerman E C I (1983) Detection of factor VIII/coagulant antigen in human liver tissue. Nature 303: 530

    CAS  Google Scholar 

  • Takahashi Y., Kalafatis M, Girma J-P, Sewerin K, Andersson L-O, Meyer D (1987) Localization of a factor VIII binding domain on a 34 kilodalton fragment of the N-terminal portion of von Willebrand factor. Blood 70: 1679

    PubMed  CAS  Google Scholar 

  • Titani K, Kumar S, Takio K, Erisson L H, Wade R D, Ashida K, Walsh K.A., Chopek M W, Sadler E, Fujikawa K (1986) Amino acid sequence of human von Willebrand factor. Biochemistry 25: 3171

    Article  PubMed  CAS  Google Scholar 

  • Tschopp T B, Weiss H J, Baumgartner H J (1974) Decreased adhesion of platelets to subendothelium in von Willebrand’s disease. J Lab Clin Med 83: 206

    Google Scholar 

  • Van Dieijen G, Tans G, Rosing J, Hemker H C (1981) The role of phospholipid and factor VIIIa in the activation of bovine factor X. J Biol Chem 256: 3433

    PubMed  Google Scholar 

  • Vehar G A, Davie E W (1980) Preparation and properties of bovine factor VIII (antihemophilic factor). Biochemistry 19: 401

    Article  PubMed  CAS  Google Scholar 

  • Verwey C L, Diergaarde P, Hart M, Pannekoek H (1986) Full-length von Willebrand factor (vWF) cDNA encodes a highly repetitive protein, considerably larger than the mature vWF subunit. EMBO J 5: 1839

    Google Scholar 

  • Verwey C L, Hart M, Pannekoek H (1987) Expression of variant von Willebrand factor (vWF) cDNA in heterologous cells: requirement of the propolypeptide in vWF multimer assembly. EMBO J 6: 2885

    Google Scholar 

  • Verwey C L, Hart M, Pannekoek H (1988) Proteolytic cleavage of the precursor of von Willebrand factor (pro-vWF) is not essential for multimer formation. J Biol Chem 263: 7921

    Google Scholar 

  • Wagner D D, Oluisted J B, Marder V J (1982) Immunolocalization of von Willebrand factor protein in Weibel Palade bodies of human endothelial cells. J Cell Biol 95: 355

    Article  PubMed  CAS  Google Scholar 

  • Wagner D D, Marder V J (1984) Biosynthesis of von Willebrand protein by human endothelial cells: processing steps and their intracellular localization. J Cell Biol 99: 2123

    Article  PubMed  CAS  Google Scholar 

  • Wion K L, Kelly D A, Summerfield J A, Tuddenham E G D, Lawn R M (1985) Distribution of factor VIII mRNA and antigen in human liver and other tissues. Nature 317: 726

    Article  PubMed  CAS  Google Scholar 

  • Wise R J, Pittman D D, Haudin R I, Kaufman R J, Orkin S H (1988) The propolypeptide of von Willebrand factor independently mediates the assembly of von Willebrand multimers. Cell 52: 229

    Article  PubMed  CAS  Google Scholar 

  • Wood W I, Capon D J, Simonsen C C, Eaton D L, Gitschier J, Keyt B, Seeburg P H, Smith D H, Hollingshead P, Wion K L, Delwart E, Tuddenham E G D, Vehar G A, Lawn R M (1984) Expression of active human factor VIII from recombinant DNA clones. Nature 312: 330

    Article  PubMed  CAS  Google Scholar 

  • Zelechowska M G, van Mourik J A, Brodniewicz-Proba T (1985) Ultra-structural localization of factor VIII procoagulant antigen in human liver hepatocytes. Nature 317: 729

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

van Mourik, J.A. et al. (1990). Biosynthesis and assembly of the factor VIII-von Willebrand factor complex. In: Harenberg, J., Heene, D.L., Stehle, G., Schettler, G. (eds) New Trends in Haemostasis. Veröffentlichungen aus der Geomedizinischen Forschungsstelle der Heidelberger Akademie der Wissenschaften, vol 1990 / 1990/3. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84318-1_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-84318-1_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-53275-0

  • Online ISBN: 978-3-642-84318-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics